COVID-19 : Up to 82% critically ill patients had low Vitamin C values

Web of Science: 28 cites, Scopus: 31 cites, Google Scholar: cites,

(Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Bielsa-Berrocal, Lara (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Universitat Autònoma de Barcelona

Data:	2021
Resum:	There are limited proven therapeutic options for the prevention and treatment of COVID-19. We underwent an observational study with the aim of measure plasma vitamin C levels in a population of critically ill COVID-19 adult patients who met ARDS criteria according to the Berlin definition. This epidemiological study brings to light that up to 82% had low Vitamin C values. Notwithstanding the limitation that this is a single-center study, it nevertheless shows an important issue. Given the potential role of vitamin C in sepsis and ARDS, there is gathering interest of whether supplementation could be beneficial in COVID-19.
Nota:	Funding: Funding Support was provided solely from institutional and/or departmental sources. No funding was provided from any of the following organizations: National Institutes of Health (NIH), Wellcome Trust, Howard Hughes Medical Institute (HHMI).
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	COVID-19 ; SARS-CoV-2 ; Vitamin C ; ARDS ; ICU ; Critically ill patient ; Epidemiology
Publicat a:	Nutrition Journal, Vol. 20 (july 2021) , ISSN 1475-2891

3 p, 635.8 KB

Registre creat el 2021-07-19, darrera modificació el 2025-08-08